Kim Hyun Jung, Baek Seunghee, Kim Hee Jin, Lee Jae Seung, Oh Yeon-Mok, Lee Sang-Do, Lee Sei Won
Department of Pulmonary and Critical Care Medicine, and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea.
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
PLoS One. 2015 Apr 27;10(4):e0125020. doi: 10.1371/journal.pone.0125020. eCollection 2015.
Although smoking is the most important and modifiable cause of chronic obstructive pulmonary disease (COPD), other risk factors including asthma and tuberculosis (TB) are also associated. It is common for COPD patients to have more than one of these risk factors. The aims of this study were to determine the prevalence of airflow limitation (FEV1/FVC<0.7) according to the risk factors and to investigate their impact and interaction in airflow limitation.
From the Korean National Health and Nutrition Examination Survey between 2008 and 2012, we analyzed participants over 40 years of age by spirometry, chest radiograph and questionnaire about asthma and smoking history.
Of 12,631 participants, 1,548 (12.3%) had airflow limitation. The prevalence of airflow limitation in smokers (≥10 pack-year), asthmatics, and those with inactive TB was 23.9%, 32.1%, and 33.6%. The prevalence increased with the number of risk factors: 86.1% had airflow limitation if they had all three risk factors. Impacts of inactive TB and asthma on airflow limitation were equivalent to 47 and 69 pack-years of smoking, respectively. Airflow limitation resulted from lower levels of smoking in those with inactive TB and asthma. A potential interaction between smoking and inactive tuberculosis in the development of airflow limitation was identified (p = 0.054).
Asthma and inactive TB lesions increase susceptibility to smoking in the development of airflow limitation. People with these risk factors should be seen as a major target population for anti-smoking campaigns to prevent COPD.
尽管吸烟是慢性阻塞性肺疾病(COPD)最重要且可改变的病因,但其他风险因素,包括哮喘和肺结核(TB)也与之相关。COPD患者通常有不止一种这些风险因素。本研究的目的是根据风险因素确定气流受限(FEV1/FVC<0.7)的患病率,并研究它们在气流受限中的影响及相互作用。
从2008年至2012年的韩国国家健康与营养检查调查中,我们通过肺活量测定、胸部X光片以及关于哮喘和吸烟史的问卷,对40岁以上的参与者进行了分析。
在12631名参与者中,1548人(12.3%)存在气流受限。吸烟者(≥10包年)、哮喘患者和非活动性肺结核患者中气流受限的患病率分别为23.9%、32.1%和33.6%。患病率随着风险因素数量的增加而上升:如果有所有三种风险因素,86.1%的人存在气流受限。非活动性肺结核和哮喘对气流受限的影响分别相当于47和69包年的吸烟量。气流受限是由非活动性肺结核和哮喘患者较低的吸烟水平导致的。在气流受限的发展过程中,吸烟与非活动性肺结核之间存在潜在的相互作用(p = 0.054)。
哮喘和非活动性结核病灶增加了气流受限发展过程中对吸烟的易感性。有这些风险因素的人群应被视为预防COPD的反吸烟运动的主要目标人群。